.jpg "Thomas K. Varghese, Jr., MD, MS, MBA, FACS, MAMSE photo")
Chief, Section of General Thoracic Surgery, University of Utah; Chief Value Officer - Huntsman Cancer Institute; Associate Chief Medical Quality Officer - HCI
University of Utah School of Medicine
Salt Lake City, Utah, United States
Dr. Thomas Varghese Jr. is Executive Medical Director (Interim) and Chief Value Officer at Huntsman Cancer Institute; Head of the Section of General Thoracic Surgery; Program Director of the Integrated Thoracic Surgery Residency and Cardiothoracic Surgery Fellowship, and a Professor (Tenure-track) in the department of Surgery at the University of Utah. Dr. Varghese holds national leadership positions in the Society of Thoracic Surgeons (STS), Thoracic Surgery Directors Association (TSDA), American College of Surgeons (ACS), Society of University Surgeons, and the National Cancer Care Network (NCCN). He serves as the Deputy Editor for Digital Media and Digital Scholarship for the Annals of Thoracic Surgery. He is a health services researcher whose academic research is on the optimization of performance at the patient, surgeon and system levels. He helped create the American College of Surgeons Strong for Surgery program (https://www.facs.org/quality-programs/strong-for-surgery and is a co-PI on the National Cancer Institute RO1-funded clinical trial on the role of Precision Exercise Prescription (PEP) for elective lung cancer surgical resection (https://clinicaltrials.gov/ct2/show/NCT03306992 ).
His other passion, in addition to his academic research, is the quest to build a better world through diversity, equity, inclusion and justice efforts. Dr. Varghese had the honor of serving as the co-chair of the Association of Women Surgeons #HeForShe TaskForce from 2017 to 2019, and currently serves as the inaugural Chair of the Society of University Surgeons Justice.Equity.Diversity.Inclusion (J.E.D.I) Committee (Term 2020-2023).
Tom spends his free time with his family, as well as actively engaging on social media.
Nothing to disclose.
Saturday, January 21, 2023
12:10 PM – 1:10 PM PT